World CB & CDx- An interview with Dr Jude O’Donnell
Ahead of the digital 11th World Clinical Biomarkers & CDx Summit (Sept29– 30), Dr Jude O’Donnell spoke to World CB & CDx on her experience of planning ahead when it comes to clinical trial assay and CDx development and tying this to Dx performance, regulatory compliance and downstream success of a drug development program.
Read the full article below- total read time 10 minutes.
You can also register for World CB & CDx here.
View Resource
Diagnostic Services
Your global partner for biomarker discovery, development & commercialisation.
Genomic Services
We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.
Clinical Trial Assays
Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.
Companion Diagnostics
A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialisation services.